SCHEMBL4574672

SCHEMBL4574672

CCOP(=O)(CSCC(=O)O)OCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.43
CYP2D6 P10635 2/20 0.42
HIF1A Q16665 1/20 0.42
PPARD Q03181 1/20 0.42
MVD P53602 1/20 0.40
TP53 P04637 2/20 0.38
MAPT P10636 2/20 0.38
GMNN O75496 1/20 0.38
POLB P06746 1/20 0.38
THRB P10828 1/20 0.38
CYP2C9 P11712 1/20 0.38
BLM P54132 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.34
MAPK1 P28482 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3889468 0.76 TSHR (0.52) TSHRPPARDTP53CYP2C9HSD17B10
SCHEMBL9674749 0.73 PPARD (0.54) TSHRPPARDTP53HSD17B10ALDH1A1
SCHEMBL31682539 0.73 PPARD (0.44) TSHRPPARDTP53TDP1
SCHEMBL13529619 0.72 TSHR (0.48) TSHRPPARDTP53HSD17B10ALDH1A1
SCHEMBL7882568 0.72 CYP2D6 (0.38) TSHRCYP2D6HIF1AMVDTP53
SCHEMBL282439 0.72 TSHR (0.52) TSHRPPARDTP53MAPTPOLB
SCHEMBL7972024 0.71 TSHR (0.46) TSHRPPARDTP53MAPTMAPK1
SCHEMBL14096888 0.71 TSHR (0.34) TSHRPPARDMAPTALDH1A1MAPK1
Propionic Acid SCHEMBL28843116 0.70 TSHR (0.71) TSHRPPARDTP53MAPTPOLB
Hydrochloric Acid SCHEMBL15439306 0.70 TSHR (0.50) TSHRPPARDTP53MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194524-A1 Compounds For the Inhibition of Undesired Cell Proliferation and Use Thereof JERINI AG (DE) 2008-08-14 US disclosed
US-20080194524-A1 Compounds For the Inhibition of Undesired Cell Proliferation and Use Thereof JERINI AG (DE) 2008-08-14 US disclosed
US-20080194524-A1 Compounds For the Inhibition of Undesired Cell Proliferation and Use Thereof JERINI AG (DE) 2008-08-14 US disclosed
EP-1703912-A1 COMPOUNDS FOR THE INHIBITION OF UNDESIRED CELL PROLIFERATION AND USE THEREOF Jerini AG (DE) 2006-09-27 EP disclosed
WO-2005063259-A1 COMPOUNDS FOR THE INHIBITION OF UNDESIRED CELL PROLIFERATION AND USE THEREOF JERINI AG (DE) 2005-07-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194524-A1 Compounds For the Inhibition of Undesired Cell Proliferation and Use Thereof CCNB1, CCNB2, CCNA1 TSHR 2312/4885CYP2D6 1594/4885HIF1A 2150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.